Pharmaceutical, Healthcare & Life Sciences – Mondaq

Apotex claimed damages allegedly sustained while it was prevented from marketing its generic omeprazole product as a result of prohibition proceedings initiated by AstraZeneca. In this decision, the Court considered Apotex’s entitlement to damages and the …

Leave a Reply

Your email address will not be published. Required fields are marked *